London, United Kingdom

Giles Brown

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Proximagen Limited. Active years: 2016-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Giles Brown. Retrieved from https://idiyas.com/inventor/giles-brown

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2016-2021

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Giles Brown

Introduction: Giles Brown is an accomplished inventor based in London, GB, known for his significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, Brown continues to make strides in developing innovative solutions that address complex medical challenges.

Latest Patents: Among his latest patents, Giles Brown has been notably recognized for his work on CXCR4 receptor antagonists. These compounds, defined by the formula (I), serve as antagonists to the CXCR4 receptor, showcasing potential therapeutic applications. The intricate details of these compounds, including the specifications for R, X, Y, and R as outlined in the claims, reflect Brown's deep understanding of medicinal chemistry and receptor biology.

Career Highlights: Brown is associated with Proximagen Limited, a company renowned for its research and development in novel therapeutics. His role within the organization allows him to leverage his expertise in the realm of innovative pharmaceutical research, contributing to groundbreaking discoveries aimed at improving patient outcomes.

Collaborations: Throughout his career, Giles has collaborated with notable colleagues Edward Savory and Alison Stewart. These professional relationships have fostered an environment of creativity and innovation, resulting in meaningful advancements in their shared field of research.

Conclusion: Giles Brown's contributions as an inventor are marked by his dedicated research and development of novel CXCR4 receptor antagonists. As he continues to work with colleagues at Proximagen Limited, Brown's innovative spirit is sure to lead to further advancements in pharmaceutical sciences, reinforcing his position as a notable figure within the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…